Profile
Simon Thelen is currently a Member-Supervisory Board at Merck KGaA, Head-Hand Surgery at Universitaetsklinikum Duesseldorf, Member-Supervisory Board at Merck Electronics KGaA, Member-Supervisory Board at Merck Healthcare KGaA, Member-Executive Board at E.
Merck KG, and Member-Supervisory Board at Merck Life Science KGaA. He obtained a doctorate degree from Universität zu Köln in 2007.
Simon Thelen active positions
| Companies | Position | Start |
|---|---|---|
| MERCK KGAA | Director/Board Member | 2019-04-25 |
E. Merck KG
E. Merck KG Pharmaceuticals: MajorHealth Technology Operates as a holding company with interests in pharmaceutical preparations | Corporate Officer/Principal | 2018-12-31 |
Merck Healthcare KGaA
Merck Healthcare KGaA Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and delivering of science-driven therapies for cancer patients | Director/Board Member | 2019-03-31 |
Universitaetsklinikum Duesseldorf | Corporate Officer/Principal | 2019-07-31 |
Merck Life Science KGaA | Director/Board Member | 2023-01-31 |
Merck Electronics KGaA | Director/Board Member | 2023-01-31 |
Training of Simon Thelen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Merck KGaA
Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Universität zu Köln
Universität zu Köln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universitaetsklinikum Duesseldorf | |
E. Merck KG
E. Merck KG Pharmaceuticals: MajorHealth Technology Operates as a holding company with interests in pharmaceutical preparations | Health Technology |
Merck Healthcare KGaA
Merck Healthcare KGaA Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and delivering of science-driven therapies for cancer patients | Health Technology |
Merck Life Science KGaA | |
Merck Electronics KGaA |
- Stock Market
- Insiders
- Simon Thelen
















